Vascular stent market seen reaching $28.21 billion by 2030

The vascular stent market is projected to grow from $17.25 billion in 2025 to $28.21 billion by 2030, according to The Business Research Company. Rising cardiovascular disease rates, more minimally invasive procedures and higher healthcare spending are driving demand.

Why it matters: - The vascular stent market sits at the center of cardiovascular care for blocked or narrowed blood vessels. - Growth in the market points to rising demand for procedures that can restore blood flow with less trauma than open surgery. - The forecast suggests continued investment in stent technology, imaging and interventional cardiology services.

What happened: - The Business Research Company released a vascular stent market outlook on Sept. 3, 2026. - The report projects the market will rise from $17.25 billion in 2025 to $19.11 billion in 2026. - The report forecasts the market will reach $28.21 billion by 2030. - The company projects a 10.8% CAGR for 2026 and a 10.2% CAGR through 2030. - The report includes a free sample and the full market report at the company’s sample report and the full vascular stent market report.

The details: - The report ties near-term growth to more cardiovascular disease cases, more catheterization lab facilities, wider acceptance of angioplasty, an aging population and broader access to interventional cardiology services. - The company says future growth will also come from advanced stent technologies, personalized cardiovascular therapies, minimally invasive cardiac care, biomaterials investment and digital imaging for guided interventions. - The report highlights rising use of drug-eluting and bioresorbable stents. - The report also points to more peripheral vascular treatments, improved long-term restenosis prevention and new alloy and polymer materials. - Vascular stents are small tubular metal mesh scaffolds used to keep blood vessels open and improve blood flow. - Vascular stents are commonly used in vascular stenting procedures to widen clogged arteries, support recovery and reduce infection risks and physical trauma. - The devices are used to treat coronary artery disease and help prevent vessel closure or restenosis. - Healthcare spending is identified as a major market driver because higher budgets can improve infrastructure, treatment access and public awareness. - The UK Office for National Statistics reported in May 2024 that total healthcare spending rose 5.6% nominally in 2023, a 0.9% increase from the prior year. - North America held the largest share of the vascular stent market in 2025. - The report also covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa.

Between the lines: - The market forecast reflects a broader shift toward less invasive cardiovascular treatment options. - The emphasis on drug-eluting, bioresorbable and image-guided technologies suggests competition will center on clinical performance and recovery outcomes, not just device volume. - North America’s leading share signals that adoption of advanced cardiovascular care remains strongest in mature healthcare systems.

What's next: - The Business Research Company says its 2026 market reports now include market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based dashboards, market hotspots infographics and updated trend analysis. - The report package also includes expanded graphics and tables for regional and technology comparisons. - The company provides sales contacts for expert follow-up and report access.

The bottom line: - The vascular stent market is on a steady expansion path, supported by rising disease burden, more advanced procedures and continued healthcare spending.